FHTX
Foghorn Therapeutics Inc
2.10$
+6.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -155.7% | -477.4% | -581.1% | -370.7% | -269.0% | -858.5% | -402.7% | -277.9% | -231.3% | -240.8% | -773.4% | -117.6% | -232.2% | |
| 4.9% | 14.8% | 16.5% | 11.6% | 9.0% | 26.6% | 13.9% | 11.3% | 11.0% | 9.2% | 7.3% | 1.4% | 6.0% | |
| 23.4% | 52.9% | 63.8% | 46.0% | 38.7% | 86.9% | 45.2% | 36.2% | 33.5% | 24.2% | 72.9% | 15.9% | 27.0% | |
| -105.8% | -142.8% | -183.2% | -140.2% | -67.0% | -284.3% | -156.0% | -102.2% | -85.1% | -88.7% | -250.5% | 44.3% | -44.1% | |
| 0.5% | 0.6% | 2.0% | 0.2% | 4.0% | 16.8% | 0.5% | 0.3% | 0.0% | 0.0% | 0.0% | 0.3% | 0.1% | |
| 219.9% | 648.0% | 536.5% | -261.0% | -785.3% | 780.5% | 494.0% | 447.7% | 436.3% | 143.1% | -542.4% | -18.5% | 76.5% | |
| – | – | – | – | – | – | – | – | – | – | – | -309.7% | – | |
| 7.9% | 3.2% | 23.1% | 1,498.3% | 13.5% | 0.1% | 2.3% | 3.4% | 0.6% | 6.3% | 1,523.5% | -309.8% | 1.7% | |
| 72.1% | 173.9% | -21.4% | 866.6% | -1,040.8% | -77.9% | 93.6% | 169.3% | 205.6% | -91.5% | 207.7% | -445.9% | -154.0% | |
| -156.2% | -478.0% | -583.1% | -371.0% | -273.0% | -875.3% | -403.2% | -278.2% | -231.3% | -240.8% | -773.4% | -117.9% | -232.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.